Welcome to Satori OCS's Europe EMA Regulatory, Registration, and Licensing Services. We offer a comprehensive range of services tailored to guide you through the intricate regulatory landscape of the European Medicines Agency (EMA). With our in-depth knowledge and expertise, we help you ensure that your products adhere to the rigorous standards set by EMA, enabling a smooth and successful market entry and operation within Europe.
The EMA is the central regulatory authority for human and veterinary medicines in the European Union (EU). It is responsible for the scientific evaluation, supervision, and safety monitoring of medicines that are marketed in the EU. The EMA works closely with national regulatory authorities in EU member states to ensure the safety and efficacy of medicines throughout the EU.
In addition to the EMA, each EU member state has its own national regulatory authority for medicines. These authorities are responsible for ensuring that medicines are safe and effective; and that they meet the same standards as those set by the EMA. They also work closely with the EMA to coordinate their activities and share information on the safety and efficacy of medicines.
Our experienced professionals develop a tailored regulatory strategy based on your objectives and provide regulatory consultation in getting your products aligned with EMA regulations. We begin with an in-depth consultation to understand your specific regulatory goals and product requirements.
We assist in preparing comprehensive documents including preparing dossiers for product registration, guiding you through the entire process.
We guide you through the submission process and liaise with EMA for approval.
Our experts help you ensure that your products meet the quality standards required by EMA, helping you navigate quality assurance processes.
We offer comprehensive support in planning, conducting, and monitoring clinical trials in accordance with EMA guidelines.
Our support extends to ongoing and post-approval compliance, monitoring and any necessary updates as per EU regulations. We offer support in ensuring post-market obligations as per EU regulations.
Our team comprises regulatory experts with in-depth knowledge of EMA regulations.
We offer tailored solutions to meet your specific product and regulatory requirements.
We streamline the regulatory process, helping timely and smooth approvals.
Our services are designed to facilitate your market entry and operation not only within Europe but also on a global scale.
From initial consultation to post-approval compliance, we provide end-to-end support.
Navigating EMA's regulatory landscape can be challenging, but with Satori OCS as your partner, you can confidently navigate the complexities and achieve successful regulatory outcomes in Europe. Contact us today for a consultation and let us guide you towards regulatory success.
The EU pharmacovigilance system requires companies to establish robust pharmacovigilance systems and conduct signal detection for adverse events. Compliance is essential for patient safety.
Experienced consultants can help companies develop regulatory strategies that consider not only European markets but also global expansion plans, ensuring efficient approvals worldwide.
Yes, IVD devices follow a separate classification system in the EU, ranging from Class A (lowest risk) to Class D (highest risk).